The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia.
Open accessAbstract
Plasma net cholesteryl ester (CE) transfer and optimum cho- lesteryl ester transfer protein (CETP) activity were determined in primary hypertriglyceridemic (a = 11) and normolipidemic (a = 15) individuals.The hypertriglyceridemic group demon- strated threefold greater net CE transfer leading to enhanced accumulation of CE in VLDL.This increased net transfer was not accompanied by a change in CETP activity.In normolipide- mia, but not in hypertriglyceridemia, net CE transfer correlated with VLDL triglyceride (r = 0.92, P < 0.001).In contrast, net CE transfer in hypertriglyceridemia, but not in normolipide- mia, correlated with CETP activity (r = 0.73, P < 0.01).Correc- tion of hypertriglyceridemia with bezafibrate reduced net CE transfer towards normal and restored the correlation with VLDL triglyceride (r = 0.90, P < 0.005) while suppressing the correlation with CETP activity.That net CE transfer depends on VLDL concentration was confirmed by an increase ofnet CE transfer in normolipidemic plasma supplemented with purified VLDL.Supplementation of purified CETP to normolipidemic plasma did not stimulate net CE transfer.In contrast, net CE transfer was enhanced by addition of CETP to both plasma supplemented with VLDL and hypertriglyceridemic plasma.Thus, in normal subjects, VLDL concentration determines the rate of net CE transfer.CETP becomes rate limiting as VLDL concentration increases, i.e, in hypertriglyceridemia. (J.Clin.Invest.1991.88:2059-2066.)Key words: cholesteryl ester transfer protein * very low density lipoprotein -high density lipoprotein -cardiovascular disease * reverse cholesterol trans- port MO.Bezafibrate (2-[4-[2-[(4-chlorobenzoyl)amino]-ethyl]phenoxy]-2methylpropanoic acid) was obtained from Boehringer Mannheim (for- merly MCP Pharmaceuticals), Livingstone, Scotland. Cholesteryl Ester Transfer in Hypertriglyceridemia 2059
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hepatic lipase and cholesterol ester transfer protein contribute to the remodeling processes; whether hepatic lipase or cholesterol ester transfer protein has the predominant effect on the size and density of LDL and HDL particles depends on the triglyceride content of very low-density lipoproteins (VLDL) (27,28).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [27]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Castelli, W. P., Doyle, J. T., Gordon, T., Hames, C. G., Hjortland, M. C., Hulley, S. B., Kagan, A., & Zukel, W. J. (1977) · Circulation · doi:10.1161/01.cir.55.5.767 · Cited by 1,492
Inazu, A., Brown, M. L., Hesler, C. B., Agellon, L. B., Koizumi, J., Takata, K., Maruhama, Y., Mabuchi, H., & Tall, A. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231803 · Cited by 862
Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38059-7 · Cited by 757
PLASMA LIPID TRANSFER PROTEINS
Tall, A. R. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.001315 · Cited by 639
Brown, M. L., Inazu, A., Hesler, C. B., Agellon, L. B., Mann, C., Whitlock, M. E., Marcel, Y. L., Milne, R. W., Koizumi, J., Mabuchi, H., et al. (1989) · Nature · doi:10.1038/342448a0 · Cited by 470
Self-citationPlasma lipid transfer proteins.
Tall, A. R. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38819-2 · Cited by 377
Agellon, L. B., Walsh, A., Hayek, T., Moulin, P., Jiang, X., Shelanski, S. A., Breslow, J. L., & Tall, A. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99088-5 · Cited by 297
Gordon, D. J., Knoke, J. D., Probstfield, J. L., Superko, H. R., & Tyroler, H. A. (1986) · Circulation · doi:10.1161/01.cir.74.6.1217 · Cited by 289
Cited by
Sorted by citations
Items 101–200 of 339
de Vries, R., Kerstens, M. N., Sluiter, W. J., Groen, A. K., van Tol, A., & Dullaart, R. P. F. (2005) · Diabetologia · doi:10.1007/s00125-005-1760-0 · Cited by 53
“Despite this elevated plasma CETP activity, plasma CET is lower particularly in male type 1 diabetic patients due to lower plasma TG and LDL cholesterol [13], indicating the importance of apo B-containing acceptor lipoproteins in plasma CE transfer [ 36 ].”
BackgroundPassarelli, M., Catanozi, S., Nakandakare, E. R., Rocha, J. C., Morton, R. E., Shimabukuro, A. F. M., & Quintão, E. C. R. (1997) · Diabetologia · doi:10.1007/s001250050791 · Cited by 52
Cholesteryl Ester Transfer Protein in Metabolic Syndrome
Sandhofer, A., Kaser, S., Ritsch, A., Laimer, M. W., Engl, J., Paulweber, B., Patsch, J. R., & Ebenbichler, C. F. (2006) · Obesity · doi:10.1038/oby.2006.94 · Cited by 51
“levels determine rate of CE transfer (26,27).”
Rebolledo, O. R., & Dato, S. M. A. (2005) · PubMed · Cited by 51
Postprandial Lipoprotein Metabolism
Sethi, S. K., Gibney, M. J., & Williams, C. M. (1993) · Nutrition Research Reviews · doi:10.1079/nrr19930011 · Cited by 50
Fournier, N., Atger, V., Cogny, A., Vedie, B., Giral, P., Simon, A. C., MOATTI, N., & Paul, J. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00730-9 · Cited by 49
Dynamics of lipoprotein transport in the human circulatory system
Fielding, P. E., & Fielding, C. J. (2002) · New comprehensive biochemistry · doi:10.1016/s0167-7306(02)36022-8 · Cited by 49
Belo, L., Gaffney, D. F., CASLAKE, M. J., Santos‐Silva, A., Pereira‐Leite, L., Quintanilha, A. T., & Rebelo, I. (2003) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(03)00240-9 · Cited by 48
“It seems that regulation of CETP activity depends on TG levels, with a positive relationship with net CE transfer evident only in the presence of high TG [39].”
BackgroundIncreased plasma cholesteryl ester transfer activity in obese children
Hayashibe, H., Asayama, K., Nakane, T., Uchida, N., Kawada, Y., & Nakazawa, S. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06014-5 · Cited by 48
“The reciprocal decrease in HDL-C occasionally found in the presence of hypertriglyceridemia may be due to an enhanced lipid transfer reaction [28].”
BackgroundIncreased Serum Cholesteryl Ester Transfer Protein in Obese Children
Asayama, K., Hayashibe, H., Dobashi, K., Uchida, N., Nakane, T., Kodera, K., & Shirahata, A. (2002) · Obesity Research · doi:10.1038/oby.2002.61 · Cited by 48
“In hypertriglyceridemia, excessive TG changes the structure of TG-rich lipoproteins and then retards cholesterol transfer from HDL, leading to a compensatory increase in CETP and the reciprocal decrease in HDLC (”
BackgroundPlasma lipoprotein abnormalities in type 1 (insulin-dependent) diabetes mellitus
Dullaart, R. P. F. (1995) · The Netherlands Journal of Medicine · doi:10.1016/0300-2977(94)00048-e · Cited by 47
Postprandial lipid metabolism in relation to coronary heart disease
Karpe, F. (1997) · Proceedings of The Nutrition Society · doi:10.1079/pns19970067 · Cited by 47
“Furthermore, Mann et al. (1991) have shown that the exchange of cholesteryl esters is enhanced with increasing plasma triacylglycerol levels in normotriacylglycerolaemic plasma, in contrast to hypertriacylglycerolaemic plasma, in which the excess of acceptor lipoprotein is sufficient to allow CETP…”
BackgroundLipoprotein profile and cholesteryl ester transfer protein in neonates
Kaser, S., Ebenbichler, C. F., Wolf, H. J., Sandhofer, A., Stanzl, U., Ritsch, A., & Patsch, J. R. (2001) · Metabolism · doi:10.1053/meta.2001.23307 · Cited by 46
Lassel, T. S., Guérin, M., Auboiron, S., Chapman, M. J., & Guy-grand, B. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.1.65 · Cited by 46
“Indeed, elevated total plasma TRL levels have been shown to increase CE mass transfer from HDL.21,24 Moreover, according to the observation of Mann et al,21 who reported elevated CETP activity in hypertriglyceridemic subjects due to a marked (fourfold) increase in VLDL levels, postprandial lipemia would be expected to…”
BackgroundInfluentialMorton, R. E., & Greene, D. J. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39178-1 · Cited by 46
Ambrosch, A., Mühlen, I., Kopf, D., Augustus, W., Dierkes, J., König, W., Luley, C. H., & Lehnert, H. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2077 · Cited by 46
Morton, R. E., Gnizak, H. M., Greene, D. J., Cho, K. H., & Paromov, V. M. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700258-jlr200 · Cited by 45
“We have proposed that this increased CETP activity on HDL happens because plasma TG, not CETP, is rate-limiting for net lipid transfer in normal plasma (6, 7).”
BackgroundEstrogen-induced small low density lipoprotein particles may be atherogenic in postmenopausal women
Wakatsuki, A., Ikenoue, N., Okatani, Y., & Fukaya, T. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01153-0 · Cited by 45
Chung, B. H., Segrest, J. P., & Franklin, F. A. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00169-5 · Cited by 45
Sugano, M., & Makino, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19080 · Cited by 45
Postprandial triacylglycerolaemia—Nutritional implications
Roche, H. M., & Gibney, M. J. (1995) · Progress in Lipid Research · doi:10.1016/0163-7827(95)00012-o · Cited by 44
Altered Transfer of Cholesteryl Esters and Phospholipids in Plasma From Alcohol Abusers
Liinamaa, J., Hannuksela, M. L., Kesäniemi, Y. A., & Savolainen, M. J. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.2940 · Cited by 42
CHOLESTERYL ESTER TRANSFER PROTEIN: ITS ROLE IN PLASMA LIPID TRANSPORT
Barter, P. J., & Rye, K. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02569.x · Cited by 43
Lottenberg, S. A., Lottenberg, A. M., Nunes, V. S., McPherson, R., & Quintão, E. C. R. (1996) · Atherosclerosis · doi:10.1016/s0021-9150(96)05938-2 · Cited by 43
Masucci-Magoulas, L., Plump, A. S., Jiang, X., Walsh, A., Breslow, J. L., & Tall, A. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118384 · Cited by 43
“These normal functions of CETP may be impaired, since E0 and LDLr0 mice do not have hypertriglyceridemia (13–15), which normally drives the cholesteryl ester transfer process (31, 32).”
BackgroundDurlach, A., Clavel, C., Girard-Globa, A., & Durlach, V. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6064 · Cited by 43
“... suggests that genetic variability of the CETP gene is likely to also have an impact on the lipid profile of NIDDM patients, but reports on the subject are few (8, 9). We have addressed the issue in a series of 406 unrelated male and female NIDDM patients explored for micro- and macrovascular complications, with pa…”
BackgroundRiemens, S. C., van Tol, A., Hoogenberg, K., van Gent, T., Scheek, L. M., Sluiter, W. J., & Dullaart, R. P. F. (1997) · Clinica Chimica Acta · doi:10.1016/s0009-8981(96)06451-0 · Cited by 42
Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG
Jonkers, I. J. A. M., Smelt, A. H. M., Hattori, H., Scheek, L. M., van Gent, T., de Man, F. H. A. F., van der Laarse, A., & van Tol, A. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300008-jlr200 · Cited by 43
“In line with earlier observations (24, 25), a higher CET was observed in HTG patients than in normolipidemic”
ResultTreatment options for hypertriglyceridemia: From risk reduction to pancreatitis
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., & Stalenhoef, A. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.002 · Cited by 50
Polyacrylamide Gradient Gel Electrophoresis of Lipoprotein Subclasses
Warnick, G. R., McNamara, J. R., Boggess, C. N., Clendenen, F., Williams, P. T., & Landolt, C. C. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.07.005 · Cited by 42
Orth, M., Weng, W., Funke, H., Steinmetz, A., Assmann, G., Nauck, M., Dierkes, J., Ambrosch, A., Weisgraber, K. H., Mahley, R. W., et al. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.5.1306 · Cited by 42
Beneficial properties of olive oil
Roche, H. M., Gibney, M. J., Kafatos, A., Zampelas, A., & Williams, C. M. (2000) · Food Research International · doi:10.1016/s0963-9969(00)00043-0 · Cited by 42
Rashid, S., Sniderman, A. D., Melone, M., Brown, P. E., Otvos, J. D., Mente, A., Schulze, K. M., McQueen, M., Anand, S. S., & Yusuf, S. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314528461 · Cited by 41
Norwitz, N. G., Soto-Mota, A., Kaplan, B., Ludwig, D. S., Budoff, M. J., Kontush, A., & Feldman, D. (2022) · Metabolites · doi:10.3390/metabo12050460 · Cited by 41
“Simply stated, higher levels of TG in apoB-containing particles drives increased CETP activity by increasing availability of TG substrate [37].”
BackgroundBagdade, J. D., Ritter, M. C., Kitabchi, A. E., Huss, E., Thistlethwaite, R. J., Gaber, A. O., & Lambeth, H. (1996) · Diabetes Care · doi:10.2337/diacare.19.10.1108 · Cited by 40
“The CETP substrates that have been shown to exert a strong positive influence on the rate of CET are the concentrations of the CE acceptor lipoproteins VLDL (10) and LDL (21).”
BackgroundElchebly, M., Porokhov, B., Pulcini, T., Berthézène, F., & Ponsin, G. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05789-7 · Cited by 39
Christine Contacos, A., Barter, P. J., Ljubica Vrga, A., & SULLIVAN, D. R. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00151-8 · Cited by 39
Cavallero, E., Dachet, C., Neufcour, D., Wirquin, E., Mathé, D., & JACOTOT, B. (1994) · Metabolism · doi:10.1016/0026-0495(94)90092-2 · Cited by 39
HDL Metabolism and Atheroprotection
Maranhão, R. C., & Freitas, F. R. (2014) · Advances in clinical chemistry · doi:10.1016/b978-0-12-800141-7.00001-2 · Cited by 40
Postprandial hyperglycaemia and vascular damage - the benefits of acarbose
Båvenholm, P., & Efendić, S. (2006) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2006.017 · Cited by 41
“The triglyceride and esterified cholesterol contained in VLDL particles are transferred to other lipoprotein species by cholesteryl ester transfer protein (CETP).(32) Hence, hypertriglyceridaemia leads to an increase in the production of triglyceride-rich VLDL, and an increase in the transfer of triglyceride to circul…”
BackgroundInduction of net mass lipid transfer reactions in plasma by wine consumption with dinner
van Tol, A., Groener, J. E. M., Scheek, L. M., van Tol, A., VEENSTRA, J., van de Pol, H., Hendriks, H., & Schaafsma, G. (1995) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1995.tb01719.x · Cited by 37
Richelle, M., Carpentier, Y., & Deckelbaum, R. J. (1994) · Biochemistry · doi:10.1021/bi00182a015 · Cited by 38
van Tol, A., Ligtenberg, J. J. M., Riemens, S. C., van Tol, A., Reitsma, W. D., & Dullaart, R. P. F. (1997) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519709056383 · Cited by 38
Beentjes, J. A. M., van Tol, A., Sluiter, W. J., & Dullaart, R. P. F. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00433-0 · Cited by 37
Hogue, J., Lamarche, B., Gaudet, D., Larivière, M., Tremblay, A. J., Bergeron, J., Lemieux, I., Després, J., Gagné, C., & Couture, P. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300420-jlr200 · Cited by 37
“tabolism, specifically LDL remodeling (29, 30).”
Postprandial lipemia and coronary risk
Patsch, W., Esterbauer, H., Föger, B., & Patsch, J. R. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0025-0 · Cited by 36
Normolipidemic Subjects With Low HDL Cholesterol Levels Have Altered HDL Subpopulations
Asztalos, B. F., LeFevre, M. L., Foster, T. A., Tulley, R. T., WINDHAUSER, M. M., Wong, L., & Roheim, P. S. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.1885 · Cited by 37
Use of fluorescent cholesteryl ester microemulsions in cholesteryl ester transfer protein assays
Bisgaier, C. L., Minton, L. L., Essenburg, A., White, A. D., & Homan, R. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36955-8 · Cited by 37
Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major
Al-Quobaili, F. (2004) · Saudi Medical Journal · doi:10.15537/1658-3175.2467 · Cited by 36
Hassanzadeh, T., Firoozrai, M., Zonouz, A. E., Zavarehee, A., & Paoli, M. (2009) · PubMed · Cited by 36
Clee, S. M., Zhang, H., Bissada, N., Li, M., Ehrenborg, E., Benlian, P., Shen, G., Ángel, A., LeBoeuf, R. C., & Hayden, M. R. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37138-8 · Cited by 36
Serdyuk, A. P., & Morton, R. E. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.718 · Cited by 36
Lagrost, L., Athias, A., Lemort, N., Richard, J.-L., Desrumaux, C. M., Châtenet-Duchêne, L., Courtois, M., Farnier, M., JACOTOT, B., Braschi, S., et al. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00299-8 · Cited by 36
“[41], CETP mass levels would be in excess in plasma from patients with moderate hypertriglyceridemia, and net mass lipid transfers, which are susceptible to alter the distribution of lipid species between various lipoprotein fractions, would be largely dependent on triglyceride levels.”
BackgroundDullaart, Riemens, Scheek, & van Tol, A. (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00521.x · Cited by 36
Durlach, V., Attia, N., Zahouani, A., Leuténegger, M., & Girard-Globa, A. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05697-1 · Cited by 35
Riemens, S. C., van Tol, A., Sluiter, W. J., & Dullaart, R. P. F. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33388-5 · Cited by 35
Wallace, A. J., Mann, J. I., Sutherland, W. H. F., Williams, S., Chisholm, A. W., Skeaff, C. M., Gudnason, V. G., Talmud, P. J., & Humphries, S. E. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00490-6 · Cited by 35
“Plasma CETP concentration does not appear to be rate-limiting for cholesteryl ester transfer when plasma triglyceride levels are below about 3 mmol/l [39].”
BackgroundJoseph, J., Shamburek, R. D., Cochran, E. K., Görden, P., & Brown, R. J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1878 · Cited by 34
“The resultant triglyceride-rich HDL-C is a good substrate for hydrolysis by hepatic lipase, which has increased activity in insulin resistance (16), and is cleared rapidly from the circulation (17, 18).”
BackgroundHbA1c negatively correlates with LCAT activity in type 2 diabetes
Nakhjavani, M., Esteghamati, A., Esfahanian, F., Ghanei, A., Rashidi, A., & Hashemi, S. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.01.018 · Cited by 34
“However, plasma triglycerides can confound any potential association because they are a major determinant of cholesterol esterification rate [10,18,19].”
BackgroundLow density lipoprotein (LDL) binding affinity for the LDL receptor in hyperlipoproteinemia
Toyota, Y., Yamamura, T., Miyake, Y., & Yamamoto, A. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00166-5 · Cited by 34
“[49] and Guérin et al.”
BackgroundApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm.
Fisher, W. R., Zech, L. A., & Stacpoole, P. W. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.4.501 · Cited by 34
“In fact, in normal subjects the availability of triglyceride becomes rate limiting for cholesterol ester transfer, and the increased transfer in HTG is largely due to the increased availability of VLDL triglyceride.(87) Accordingly, one might anticipate that a low plasma triglyceride concentration in FH should correla…”
Backgroundvan der Hoorn, J., Jukema, J. W., Havekes, L. M., Lundholm, E., Camejo, G., Rensen, P. C. N., & Princen, H. M. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00109.x · Cited by 33
“…reduced to a larger extent than CETP mass may relate to the large reduction in plasma triglycerides, as the capacity of apoB-containing lipoproteins to accept cho- lesteryl esters from HDL is closely correlated to its plasma level (Mann et al., 1991; Marzetta et al., 1993; Guerin et al., 1994a,b).”
BackgroundMorton, R. E., Liu, Y., & Izem, L. (2019) · Journal of Lipid Research · doi:10.1194/jlr.ra119000171 · Cited by 34
“CETP activity is strongly influenced by plasma TG levels and is typically not rate limiting when TG-rich lipoprotein levels are low (35, 36).”
BackgroundClearance of postprandial lipoproteins in normolipemics: role of the apolipoprotein E phenotype
Orth, M., Wahl, S., Hanisch, M., Friedrich, I., Wieland, H., & Luley, C. H. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00075-6 · Cited by 33
Ritter, M. C., & Bagdade, J. D. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb01112.x · Cited by 33
de Barros, J.-P. P., Boualam, A., Gautier, T., Dumont, L., Vergès, B. L., Masson, D., & Lagrost, L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800588-jlr200 · Cited by 32
Quintão, E. C. R. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05531-z · Cited by 32
Kappelle, P. J. W. H., Perton, F. G., Hillege, H. L., Dallinga‐Thie, G. M., & Dullaart, R. P. F. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.020 · Cited by 31
Couch, S. C., Isasi, C. R., Karmally, W., Blaner, W. S., Starc, T. J., Nitzan, D., Deckelbaum, R. J., Ginsberg, H. N., Shea, S., & Berglund, L. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.5.1119 · Cited by 31
Kahri, J., Syvänne, M., & Taskinen, M. (1994) · Metabolism · doi:10.1016/0026-0495(94)90007-8 · Cited by 31
Ethanol-Induced Redistribution of Cholesteryl Ester Transfer Protein (CETP) Between Lipoproteins
Hannuksela, M. L., Rantala, M., Kesäniemi, Y. A., & Savolainen, M. J. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.2.213 · Cited by 31
Effects of nasal immunization of multi-target preventive vaccines on atherosclerosis
Long, J., Jie, L., Dongping, Y., Yang, X., Li, T., Rongyue, C., Wu, J., & Jingjing, L. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.12.043 · Cited by 30
Increased Cholesteryl Ester Transfer Activity in Plasma From Analbuminemic Patients
Braschi, S., Lagrost, L., Florentin, E., Martin, C., Athias, A., Gambert, P., Krempf, M., Lallemant, C., & JACOTOT, B. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.3.441 · Cited by 30
Lottenberg, A. M., Nunes, V. S., Lottenberg, S. A., Shimabukuro, A. F. M., Carrilho, A. J. F., Malagutti, S., Nakandakare, E. R., McPherson, R., & Quintão, E. C. R. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05914-x · Cited by 30
Hypercatabolism of lipoprotein-free apolipoprotein A-I in HDL-deficient mutant chickens.
Schreyer, S. A., Hart, L. K., & Attie, A. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.12.2053 · Cited by 30
Sich, D., Saïdi, Y., Giral, P., Lagrost, L., Egloff, M., Auer, C., Gautier, V., Turpin, G., & Beucler, I. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90352-3 · Cited by 29
Dachet, C. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05411-b · Cited by 29
Jones, R. J., Owens, D., Brennan, C., Collins, P. B., Johnson, A. H., & Tomkin, G. H. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05639-4 · Cited by 29
Nishizawa, Y., Shoji, T., Nishitani, H., Yamakawa, M., Konishi, T., Kawasaki, K., & Morii, H. (1993) · Kidney International · doi:10.1038/ki.1993.388 · Cited by 29
Sutherland, W. H. F., Walker, R. J., Lewis-Barned, N. J., Pratt, H., & Tillman, H. C. (1994) · Metabolism · doi:10.1016/0026-0495(94)90028-0 · Cited by 29
Gender differences in the development of hyperlipemia and atherosclerosis in hybrid hamsters
Robins, S. J., Fasulo, J. M., Patton, G. M., Schaefer, E. J., Smith, D. E., & Ordovás, J. M. (1995) · Metabolism · doi:10.1016/0026-0495(95)90038-1 · Cited by 28
Apolipoproteins AI and B as therapeutic targets
Charlton-Menys, V., & Durrington, P. N. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01646.x · Cited by 28
Plasma cholesteryl ester transfer in patients with non-insulin dependent diabetes mellitus
Sutherland, W. H. F., Walker, R. J., Lewis-Barned, N. J., Pratt, H., & Tillman, H. C. (1994) · Clinica Chimica Acta · doi:10.1016/0009-8981(94)90251-8 · Cited by 28
Determination of lipid transfer inhibitor protein activity in human lipoprotein-deficient plasma.
Morton, R. E., & Steinbrunner, J. V. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.12.1843 · Cited by 28
Ordovás, J. M. (2000) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2000.139 · Cited by 27
Therapeutic Effects of Fibrates in Postprandial Lipemia
Kolovou, G. D., Kostakou, P. M., Anagnostopoulou, K. K., & Cokkinos, D. V. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200808040-00004 · Cited by 27
Moreno, J. A., Pérez‐Jiménez, F., Marı́n, C., Gómez, P., Pérez‐Martínez, P., Moreno‐Luna, R., Bellido, C., Fuentes, F. J., & López‐Miranda, J. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.5.1404 · Cited by 27
“In the postprandial state, it is postulated that the extent of exchange may be determined by particle residence time in the circulation (38).”
BackgroundOkumura, K., Matsui, H., Kamiya, H., Saburi, Y., Hayashi, K., & Hayakawa, T. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00653-0 · Cited by 26
Effect of gemfibrozil on the regulation of HDL subfractions in hypertriglyceridaemic patients
Kahri, J., Sane, T., van Tol, A., & Taskinen, M. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01220.x · Cited by 27
Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL
Murdoch, S. J., & Breckenridge, W. C. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00105-1 · Cited by 26
Ahnadi, C.-E., Masmoudi, T., Berthezène, F., & Ponsin, G. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00791.x · Cited by 26
Dyslipidaemia in type 2 diabetes: epidemiology and biochemistry
Valabhji, J., & Elkeles, R. S. (2003) · The British Journal of Diabetes · doi:10.1177/14746514030030030501 · Cited by 25
Fibrates inhibit aldose reductase activity in the forward and reverse reactions
Balendiran, G. K., & Rajkumar, B. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.06.029 · Cited by 25
Role of Lp A-I and Lp A-I/A-II in Cholesteryl Ester Transfer Protein–Mediated Neutral Lipid Transfer
McPherson, R., Agnani, G., Lau, P., Fruchart, J., Edgar, A. D., & Marcel, Y. L. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.11.1340 · Cited by 25
Effects of pancreas transplantation on distribution and composition of plasma lipoproteins
Föger, B., Königsrainer, A., Pálos, G., Ritsch, A., Tröbinger, G., Menzel, H.-J., Lechleitner, M., Doblinger, A., König, P., Utermann, G., et al. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90159-6 · Cited by 25
The effects of hypothyroidism and replacement therapy on cholesteryl ester transfer
Ritter, M. C., Kannan, C. R., & Bagdade, J. D. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.2.797 · Cited by 24
Noone, E., Roche, H. M., Black, I. L., Tully, A.-M., & Gibney, M. J. (2000) · British Journal Of Nutrition · doi:10.1017/s0007114500001434 · Cited by 24
Chung, B. H., Franklin, F. A., Cho, B. H. S., Segrest, J. P., Hart, K. L., & Darnell, B. E. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.8.1217 · Cited by 24
Schrama, Y. C., Hen, R. J., de Jonge, N., Joles, J. A., van Rijn, H. J. M., r, D. R. B., Ververs, T. F., van Tol, A., & Koomans, H. A. (1998) · Transplantation · doi:10.1097/00007890-199811150-00011 · Cited by 24
Suppression of Lipid Transfer Inhibitor Protein Activity by Oleate
Morton, R. E., & Greene, D. J. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.3041 · Cited by 24
Metadata
- Authors
- Mann, C. J., Yen, F. T., Grant, A. M., & Bihain, B. E.
- Affiliations
- Louisiana State University (US)
- ORCID
- Yen, F T
- Venue
- Journal of Clinical Investigation
- Published
- 1991-12-01
- Volume
- 88
- Issue
- 6
- Pages
- 2059-2066
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2114689977
- Cited by
- 339
- References
- 30
- Citations by year
- 2024: 5 · 2023: 3 · 2022: 5 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 2 · 2014: 10 · 2013: 1 · 2012: 2
- FWCI
- 17.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01hl025596-15)
- National Heart, Lung, and Blood Institute (HL255-96)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- cholesteryl ester transfer, cholesteryl ester transfer protein, hypertriglyceridemia, VLDL, VLDL triglycerides, reverse cholesterol transport, CETP activity, bezafibrate, lipoprotein metabolism, rate-determining step
- MeSH terms
- Adult, Bezafibrate, Biological Transport, Carrier Proteins, Cholesterol Esters, Glycoproteins, Humans, Lipoproteins, HDL, Lipoproteins, LDL, Lipoproteins, VLDL, Triglycerides, Hypertriglyceridemia, Cholesterol Ester Transfer Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review